Ms Erin Gary, PLMSW | |
110 Pearson, Benton, AR 72015-4436 | |
(501) 315-4224 | |
(501) 778-0450 |
Full Name | Ms Erin Gary |
---|---|
Gender | Female |
Speciality | Social Worker |
Location | 110 Pearson, Benton, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306289517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
104100000X | Social Worker | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Erin Gary, PLMSW 110 Pearson, Benton, AR 72015-4436 Ph: (501) 315-4224 | Ms Erin Gary, PLMSW 110 Pearson, Benton, AR 72015-4436 Ph: (501) 315-4224 |
News Archive
Kidney cancer patients may soon have an alternative to traditional treatments, new research at UT Southwestern Medical Center's Kidney Cancer Program of the Harold C. Simmons Comprehensive Cancer Center shows.
Maintaining glycemic control does not reduce the likelihood for cardiovascular disease leading to hospitalization in people with Type 2 diabetes, report US researchers.
The Wall Street Journal reports on how a number of policies and market forces are combining to put added pressure on rural hospitals. Meanwhile, other news outlets report on the challenge of making the health system affordable and the health law's new options for pregnant women.
Agence France-Presse reports that the U.N. has launched "a new website to track the estimated 9.9 billion dollars in aid pledged to Haiti by the international community in the wake of a devastating January 12 earthquake." The website is a joint project of the Haitian government and the U.N. Development Programme.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
› Verified 5 days ago